>>Signaling Pathways>> Microbiology & Virology>> Parasite>>Moxidectin

Moxidectin (Synonyms: CL-301423)

Catalog No.GC17083

Moxidectin(ProHeart 6; CL301423; Cydectin)은 기생충(기생충)을 죽이는 구충제로 심장사상충 및 장내충의 예방 및 방제에 사용됩니다.

Products are for research use only. Not for human use. We do not sell to patients.

Moxidectin Chemical Structure

Cas No.: 113507-06-5

Size 가격 재고 수량
1mg
US$108.00
Ship Within 10-14 Days

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Moxidectin(ProHeart 6; CL301423; Cydectin) is an anthelmintic drug which kills parasitic worms (helminths), and is used for the prevention and control of heartworm and intestinal worms.IC50 value:Target: Anti-parasiticMoxidectin is a semisynthetic derivative of nemadectin, which is produced by fermentation by Streptomyces cyano-griseus. Moxidectin treats and controls some of the most common internal and external parasites by selectively binding to a parasite's glutamate-gated chloride ion channels. These channels are vital to the function of invertebrate nerve and muscle cells; when moxidectin binds to the channels, it disrupts neurotransmission, resulting in paralysis and death of the parasite. Studies of moxidectin show the side effects vary by animal and may be affected by the product’s formulation, application method and dosage.

References:
[1]. Moxidectin, From Wikipedia

리뷰

Review for Moxidectin

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Moxidectin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.